ArticleJournal of bone oncology2016

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.

C L Addison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.